Medical Communications
Bristol Myers Squibb works with SpaceX to study biomanufacturing in space
March 16, 2023 Medical Communications
It was announced last week that the SpaceX Dragon spacecraft will make its journey to the International Space Station (ISS) …
Cough medicines containing pholcodine withdrawn across UK
March 15, 2023 Medical Communications
Some cough syrups being sold behind the counter at pharmacies are being withdrawn due to safety concerns surrounding potential allergies …
FDA amends EUA of Pfizer-BioNTech COVID-19 vaccine for paediatric use
March 15, 2023 Medical Communications
Yesterday, the FDA announced that it has amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech bivalent COVID-19 Vaccine. The …
BlueRock Therapeutics collaboration over Parkinson’s disease digital health technology
March 15, 2023 Medical Communications
Clinical stage biopharmaceutical company BlueRock Therapeutics has announced a collaboration with Rune Labs and Emerald Innovations. It will look at …
US bill pushes Medicare and Medicaid categories for prescription digital therapeutics
March 14, 2023 Medical Communications
Both the US House of Representatives and Senate are considering a bill which would encourage the adoption of prescription digital …
Nasal spray that relieves migraines in minutes approved by FDA
March 13, 2023 Medical Communications
Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …
Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug
March 13, 2023 Medical Communications
Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …
Biotech centre focusing on gene therapies opens in Bristol, UK
March 10, 2023 Medical Communications
A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …
FDA committee supports Roche’s lymphoma treatment
March 10, 2023 Medical Communications
A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …
Respiree gets FDA clearance for cardio-respiratory wearable
March 9, 2023 Medical Communications
Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable. RS001 is a …
Abbott’s concussion-detecting blood test approved by FDA
March 8, 2023 Medical Communications
US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …
Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients
March 8, 2023 Medical Communications
Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …
FDA grants de novo approval to Neuromod’s tinnitus device
March 8, 2023 Medical Communications
The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …
BioMarin receives FDA update for gene therapy for adults with severe haemophilia A
March 7, 2023 Medical Communications
Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their …
Sooma receives FDA Breakthrough Device designation for depression therapy device
March 7, 2023 Medical Communications
Finnish company Sooma Medical has received Breakthrough Device designation by the FDA for its portable, at-home neuromodulation device to treat …
Latest content
October 26, 2026
